Popular Articles
Today Week Month Year


GENETIC HARVESTING: Covid testing firm admits to selling covid swabs containing customer DNA to third parties
By Ethan Huff // Nov 22, 2021

Cignpost Diagnostics, a government-approved supplier of the Wuhan coronavirus (Covid-19) "Express Test," has announced that it is planning to start selling swabs that contain customers' DNA to third parties.

Brighteon.TV

A U.K.-based data privacy watchdog group has launched an investigation into the development, which breaches numerous privacy laws. The company, meanwhile, claims the new profiteering endeavors is needed to "learn more about human health" in order to develop new drug products.

One major problem with all this is that Cignpost never notified anyone who took any of its swab tests about its intention. Instead, the company feigned that it was simply testing for the presence of Chinese Germs. (RELATED: At-home DNA testing kits are just as shady and believed to be part of a genetics harvesting scheme.)

Customers who took the tests were initially asked to tick a box agreeing to a 4,876-word privacy policy, which reportedly links to another document outlining the company's "research programme."

"Typically, analysis of sensitive medical information can only be carried out with explicit informed consent," reported The Central London.

Cignpost, which has 71 walk-in locations across the United Kingdom, is said to have delivered as many as three million Fauci Flu tests since June 2020. Each test, of the PCR variety, costs between £35 (about $47) and £120 (about $162).

At roughly three million and counting, this means that Cignpost has raked in anywhere between $141 million and $486 million.

Is covid testing a massive DNA harvesting, profit generation scheme in disguise?

October 21 is the last time that Cignpost updated its "research programme information sheet." The latest version indicates that the company retains customer data, including "biological samples" and "the DNA obtained from such samples."

Cignpost also retains "genetic information derived from processing your DNA sample," the document now reads, adding that this is done "using various technologies such as genotyping and whole or partial genome sequencing."

Also included in the Cignpost policy document is a caveat about how customers' DNA samples and other personal information will be shared with "collaborators" either working with the company or independently. These collaborators include universities and private companies, which Cignpost says "may receive compensation" in return for their cooperation with the scheme.

"It is unclear how many samples have been stored by Cignpost or whether they have been sold or used for any research so far, but the policy says that data belonging to all those providing a swab is retained indefinitely," added The Central London.

Just to be clear, the $141-$486 million in profits generated by Cignpost are just for the normal testing procedure. These third-party sales of the swabs and their DNA to third parties is additional profit that the company is raking in under hidden terms in its privacy policy.

"Let me give you a clue as to what is going on here," reported Verum Et Inventa.

"Family history companies have been taking DNA samples from people already, and the rumor is that they could be selling the info as well. The Powers That Be want to get their hands on these samples, but why? BECAUSE THEY ARE LOOKING FOR SOMEONE OR ONE SPECIFIC GENOME OF PEOPLE."

What could this specific genome be? The jury is still out on that one, but more people are asking questions, at least, and that is a move in the right direction.

"And any company that does blood, urine, or other bodily fluids don't go through China?" asked one commenter at Natural News.

"Yep, read the fine print when you go to a doctor," responded another.

The latest news about this and other plandemic profit schemes can be found at Fascism.news.

Sources for this article include:

The-Central-London.uk

NaturalNews.com

VerumEtInventa.wordpress.com



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.